| ²é¿´: 1018 | »Ø¸´: 15 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û13´Î£¬×÷Õßgavin_yan83Ôö¼Ó½ð±Ò 11.5 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
[·ÖÏíÒ©¼ÁºÃÊé]Excipient Development for Pharmaceutical, Biotechnology, and DDS
|
||
|
Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems Informa Healthcare | ISBN: 0849327067 | 2006-07-28 | PDF | 452 pages | 4.29 Mb | RS To facilitate the development of novel drug delivery systems and biotechnology-oriented drugs, the need for new, yet to be developed, and approved excipients continues to increase. Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems serves as a comprehensive source to improve understanding of excipients and forge potential new avenues for regulatory approval. This book presents detailed, up-to-date information on various aspects of excipient development, testing, and technological considerations for their use. It addresses specific details such as historical perspective, preclinical testing, safety, and toxicology evaluation, as well as regulatory, quality, and utility aspects. The text also describes best practices for use of various functional excipients and extensive literature references for all topics. [ Last edited by gavin_yan83 on 2007-12-17 at 09:36 ] |
» ²ÂÄãϲ»¶
353Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á
ÒѾÓÐ11È˻ظ´
µ÷¼Á
ÒѾÓÐ8È˻ظ´
¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸±±¾©2£¬²ÄÁÏÓ뻯¹¤308Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸µç×ӿƼ¼´óѧ085600²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
hongweiwei000
ÈÙÓþ°æÖ÷ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 2.28
- ½ð±Ò: 12313.9
- Ìû×Ó: 2249
- ÔÚÏß: 184.5Сʱ
- ³æºÅ: 420620
4Â¥2007-12-22 22:07:00
dnazyme
¾èÖú¹ó±ö (ÖªÃû×÷¼Ò)
- Ó¦Öú: 28 (СѧÉú)
- ¹ó±ö: 0.1
- ½ð±Ò: 2464.5
- Ìû×Ó: 6027
- ÔÚÏß: 2034.6Сʱ
- ³æºÅ: 35203
2Â¥2007-12-16 22:47:05
6Â¥2007-12-23 11:08:31
7Â¥2008-01-05 12:19:24














»Ø¸´´ËÂ¥